APA (7th ed.) Citation

LS, L., M, S., B, F., J, S., A, A., N, H., . . . CJ, D. (2026). Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression. Frontiers in immunology, 17, 1766555. https://doi.org/10.3389/fimmu.2026.1766555

Chicago Style (17th ed.) Citation

LS, Lau, et al. "Glycoengineering CAR-T Cells to Overcome Galectin-3-mediated Immunosuppression." Frontiers in Immunology 17 (2026): 1766555. https://doi.org/10.3389/fimmu.2026.1766555.

MLA (9th ed.) Citation

LS, Lau, et al. "Glycoengineering CAR-T Cells to Overcome Galectin-3-mediated Immunosuppression." Frontiers in Immunology, vol. 17, 2026, p. 1766555, https://doi.org/10.3389/fimmu.2026.1766555.